Cardinal Health CAH Business Segments
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cost of product sold | $3.15B-3.4% | $3.26B+2.4% | $3.18B-0.5% | $3.2B+1.2% | $3.16B+0.2% | |
| Other Segments | $1.71B-1.0% | $1.72B+5.1% | $1.64B+2.0% | $1.61B+23.4% | $1.3B+1.6% | |
| Pharmaceutical and Specialty Solutions | $56.11B-7.5% | $60.67B+2.5% | $59.21B+6.9% | $55.37B+9.8% | $50.43B-0.8% | |
| Total Assets by Business | ||||||
| Cost of product sold | $6.89B-1.5% | $6.99B-2.0% | $7.13B+3.5% | $6.89B-4.3% | $7.2B+2.1% | |
| Other Segments | $4.07B-0.2% | $4.07B+0.6% | $4.05B+0.1% | $4.05B+48.4% | $2.73B+0.2% | |
| Pharmaceutical and Specialty Solutions | $41.03B-5.5% | $43.41B+12.2% | $38.68B+3.7% | $37.31B+4.4% | $35.73B+11.2% | |
| Total operating earnings by Business | ||||||
| Cost of product sold | $25M-32.4% | $37M-19.6% | $46M-34.3% | $70M+79.5% | $39M+117% | |
| Other Segments | $179M0.0% | $179M+7.8% | $166M+3.8% | $160M+19.4% | $134M+13.6% | |
| Pharmaceutical and Specialty Solutions | $784M+14.1% | $687M+3.0% | $667M+24.7% | $535M-19.2% | $662M+24.7% | |
| Costs and Expenses by Business | ||||||
| Cost of product sold | $3.12B-3.1% | $3.22B+2.7% | $3.14B+0.3% | $3.13B+0.3% | $3.12B-0.5% | |
| Other Segments | $1.53B-1.2% | $1.55B+4.7% | $1.48B+1.8% | $1.45B+23.8% | $1.17B+0.4% | |
| Pharmaceutical and Specialty Solutions | $55.33B-7.8% | $59.98B+2.5% | $58.54B+6.7% | $54.84B+10.2% | $49.77B-1.1% | |
| Cost of products sold by Business | ||||||
| Cost of product sold | $2.61B-4.2% | $2.72B+3.3% | $2.63B+1.0% | $2.61B-1.0% | $2.63B+0.4% | |
| Other Segments | $1.27B-1.8% | $1.29B+5.7% | $1.22B+2.2% | $1.2B+22.6% | $975M+0.6% | |
| Pharmaceutical and Specialty Solutions | $54.6B-7.8% | $59.24B+2.4% | $57.86B+6.8% | $54.17B+10.2% | $49.17B-1.2% | |
| Segment Reporting, Long-Lived Asset, Expenditure for Addition by Business | ||||||
| Cost of product sold | $32M+39.1% | $23M+21.1% | $19M-68.9% | $61M+118% | $28M+33.3% | |
| Other Segments | $25M+8.7% | $23M+53.3% | $15M-58.3% | $36M+100% | $18M-18.2% | |
| Pharmaceutical and Specialty Solutions | $37M+60.9% | $23M-28.1% | $32M-48.4% | $62M+87.9% | $33M+175% | |
| D&A by Business | ||||||
| Cost of product sold | $54M-1.8% | $55M0.0% | $55M+17.0% | $47M-16.1% | $56M-6.7% | |
| Other Segments | $26M-13.3% | $30M+3.4% | $29M— | $0-100% | $31M-22.5% | |
| Pharmaceutical and Specialty Solutions | $70M+9.4% | $64M+4.9% | $61M-10.3% | $68M+54.5% | $44M-4.3% | |
| Goodwill by Business | ||||||
| Cost of product sold | $0— | $0— | $0— | $0— | $0— | |
| Other Segments | $1.75B-0.1% | $1.75B+0.2% | $1.75B-0.2% | $1.75B+49.4% | $1.17B0.0% | |
| Pharmaceutical and Specialty Solutions | $9.67B-2.0% | $9.86B+23.8% | $7.97B+0.3% | $7.94B+2.7% | $7.74B+79.2% | |
| Distribution, selling, general and administrative expenses by Business | ||||||
| Cost of product sold | $518M+3.2% | $502M-0.6% | $505M-3.1% | $521M+7.0% | $487M-4.9% | |
| Other Segments | $259M+2.0% | $254M0.0% | $254M0.0% | $254M+30.3% | $195M-0.5% | |
| Pharmaceutical and Specialty Solutions | $732M-0.9% | $739M+8.5% | $681M+2.6% | $664M+9.9% | $604M+6.3% | |
| Goodwill, Impairment Loss by Business | ||||||
| Pharmaceutical and Specialty Solutions | $184M— | —— | —— | —— | —— | |
| Goodwill, Acquired During Period by Business | ||||||
| Cost of product sold | $0— | $0— | $0— | $0— | $0— | |
| Other Segments | -$1M-133% | $3M+200% | -$3M-101% | $578M— | $0— | |
| Revenue by Geography | ||||||
| Non-US | $423M-2.8% | $435M+3.8% | $419M-3.5% | $434M+8.8% | $399M-6.8% | |
| UNITED STATES | $60.54B-7.2% | $65.22B+2.5% | $63.61B+6.5% | $59.75B+9.6% | $54.5B-0.7% | |
| PP&E (Net) by Geography | ||||||
| Non-US | $434M+0.5% | $432M-0.7% | $435M-0.2% | $436M— | —— | |
| UNITED STATES | $2.49B+2.0% | $2.45B+2.0% | $2.4B-1.1% | $2.42B— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cardinal Health break its business down?
- Cardinal Health (CAH) reports revenue by business across 3 parts — Cost of product sold, Other Segments and Pharmaceutical and Specialty Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Cardinal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cardinal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
